Published in Urol Clin North Am on August 01, 2000
Wilms tumour: prognostic factors, staging, therapy and late effects. Pediatr Radiol (2007) 2.31
Clinical trials to improve childhood cancer care and survival in sub-Saharan Africa. Nat Rev Clin Oncol (2013) 1.44
The management of synchronous bilateral Wilms tumor: a report from the National Wilms Tumor Study Group. Ann Surg (2011) 1.13
miRNA profiles as a predictor of chemoresponsiveness in Wilms' tumor blastema. PLoS One (2013) 1.02
Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. J Clin Oncol (2015) 0.93
Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model. PLoS One (2011) 0.92
Role of MRI in the management of patients with nephroblastoma. Eur Radiol (2008) 0.88
Treatment-independent miRNA signature in blood of Wilms tumor patients. BMC Genomics (2012) 0.86
The management of nephroblastoma with cavo-atrial disease at presentation: experience from a developing country. Pediatr Surg Int (2010) 0.81
The morbidity and outcome of surgery in children with large pre-treated Wilms' tumour: size matters. Pediatr Surg Int (2006) 0.80
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients. Oncotarget (2017) 0.75
Post-genomic clinical trials: the perspective of ACGT. Ecancermedicalscience (2008) 0.75
The standardized histogram shift of t2 magnetic resonance image (MRI) signal intensities of nephroblastoma does not predict histopathological diagnostic information. Cancer Inform (2015) 0.75
Preoperative chemotherapy and local stage III in nephroblastoma. Transl Pediatr (2014) 0.75
A rare case of simultaneous occurrence of Wilms' tumor in the left kidney and the bladder. Pediatr Surg Int (2010) 0.75
Secondary neoplasms after Wilms' tumor in Germany. Strahlenther Onkol (2009) 0.75
Initial Surgery in Tailoring Treatment for Children With Stage II and III Wilms' Tumor: An Experience From Resource Challenged Settings. World J Oncol (2015) 0.75
Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med (1996) 2.66
Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol (1993) 1.88
Diabetes mellitus after abdominal radiation therapy. Lancet (1995) 1.79
Somatic mosaicism for partial paternal isodisomy in Wiedemann-Beckwith syndrome: a post-fertilization event. Eur J Hum Genet (1993) 1.57
Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet (1993) 1.55
How to establish equivalence between treatments: a one-sided clinical trial in paediatric oncology. Stat Med (1989) 1.50
New definitions of focal and diffuse anaplasia in Wilms tumor: the International Society of Paediatric Oncology (SIOP) experience. Med Pediatr Oncol (1999) 1.47
Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet (1995) 1.45
Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol (2001) 1.45
The role of chemotherapy, surgery, and radiotherapy in rhabdomyosarcoma of the orbit. Pediatr Hematol Oncol (1992) 1.42
Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol (1983) 1.39
Wilms' tumor: natural history and prognostic factors: a retrospective study of 248 cases treated at the Institut Gustave-Roussy 1952-1967. Cancer (1976) 1.39
Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet (1988) 1.36
Cytosine-arabinoside, vincristine, and prednisolone in the treatment of children with disseminated Langerhans cell histiocytosis with organ dysfunction: experience at a single institution. Med Pediatr Oncol (1993) 1.34
Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod (2001) 1.28
Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet (2004) 1.27
Is partial nephrectomy appropriate treatment for unilateral Wilms' tumor? J Pediatr Surg (1998) 1.14
Hyperaminoaciduria identifies patients at risk of developing renal tubular toxicity associated with ifosfamide and platinate containing regimens. Med Pediatr Oncol (1992) 1.13
Lymph node invasion and prognosis in nephroblastoma. Cancer (1980) 1.13
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites. Clin Pharmacokinet (2001) 1.12
Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Eur J Cancer (2013) 1.12
Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9. Med Pediatr Oncol (2000) 1.09
A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res (1998) 1.07
Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer (2001) 1.05
Radionuclide diagnosis and therapy of neural crest tumors using iodine-131 metaiodobenzylguanidine. J Nucl Med (1987) 1.04
Metastasized angiosarcoma of the spleen in a 2-year-old girl. Pediatr Hematol Oncol (2005) 1.02
Ifosfamide, mesna and vincristine in paediatric oncology. Cancer Treat Rev (1983) 0.98
The role of preoperative chemotherapy in the treatment of nephroblastoma: the SIOP experience. Societe Internationale d'Oncologie Pediatrique. Semin Urol Oncol (1999) 0.97
Veno-occlusive disease of the liver in children treated for Wilms tumor. Med Pediatr Oncol (1997) 0.97
Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus. Hum Genet (1996) 0.97
Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis. Genes Chromosomes Cancer (1995) 0.96
Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9". International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. Eur J Pediatr Surg (1998) 0.95
Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. J Clin Oncol (1990) 0.94
Hypercalcemia preferentially occurs in unusual forms of childhood non-Hodgkin's lymphoma, rhabdomyosarcoma, and Wilms' tumor. A study of 11 cases. Cancer (1984) 0.94
Etoposide and carboplatin: a highly effective combination in relapsed or refractory Wilms' tumor--a phase II study by the French Society of Pediatric Oncology. J Clin Oncol (1994) 0.94
Bilateral Wilms' tumor: long-term survival and some epidemiological features. J Clin Oncol (1989) 0.93
Loss of heterozygosity in Wilms' tumors, studied for six putative tumor suppressor regions, is limited to chromosome 11. Cancer Res (1990) 0.92
Prognostic factors in surgery for pulmonary metastases in children. Surgery (1994) 0.91
Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med (1997) 0.91
Incidence and outcomes of patients with late recurrence of Wilms' tumor. Pediatr Blood Cancer (2013) 0.90
[Langerhans-cell histiocytosis (histiocytosis X); 20-year experience in the Emma Kinderziekenhuis, 1969-1988]. Ned Tijdschr Geneeskd (1993) 0.90
High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: a French Society of Pediatric Oncology study. J Clin Oncol (1998) 0.89
Etoposide in relapsed or refractory Wilms' tumor: a phase II study by the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 0.89
Results of treatment with 131 I-metaiodobenzylguanidine (131 I-MIBG) in patients with neuroblastoma. Future prospects of zetotherapy. Prog Clin Biol Res (1991) 0.88
Del 11p/aniridia complex. Report of three patients and review of 37 observations from the literature. Clin Genet (1984) 0.88
Recurrent 1;17 translocations in human neuroblastoma reveal nonhomologous mitotic recombination during the S/G2 phase as a novel mechanism for loss of heterozygosity. Am J Hum Genet (1994) 0.88
[Neuroblastomas treated at the Gustave-Roussy Institute from 1975 to 1979. 173 cases]. Arch Fr Pediatr (1983) 0.88
Population pharmacokinetics of ifosfamide and its dechloroethylated and hydroxylated metabolites in children with malignant disease: a sparse sampling approach. Clin Pharmacokinet (2001) 0.88
Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. Med Pediatr Oncol (1999) 0.88
[Treatment of childhood cancer in Africa. Preliminary results of the French-African paediatric oncology group]. Arch Pediatr (2005) 0.88
Testicular tumor concomitant with von Recklinghausen's disease. Med Pediatr Oncol (1988) 0.88
Intraoperative search for neuroblastoma by MIBG and radioguided surgery with the gamma detector. Med Pediatr Oncol (1997) 0.87
Mesoblastic nephromas: a study of 29 tumours from the SIOP nephroblastoma file. Histopathology (1985) 0.87
Primary nephrectomy for emergency: a rare event in the International Society of Paediatric Oncology Nephroblastoma Trial and Study no. 9. Eur J Pediatr Surg (2001) 0.87
Childhood paroxysmal nocturnal haemoglobinuria (PNH), a report of 11 cases in the Netherlands. Br J Haematol (2005) 0.86
WT1 splicing alterations in Wilms' tumors. Clin Cancer Res (2000) 0.85
Abdominal recurrences in Wilms' tumours: a report from the SIOP Wilms' tumour trials and studies. Radiother Oncol (1986) 0.85
Genetics and epidemiology of Wilms' tumor: the French Wilms' tumor study. Med Pediatr Oncol (1992) 0.84
A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med (2001) 0.84
Endocrine late effects from multi-modality treatment of neuroblastoma. Eur J Cancer (2005) 0.83
Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma. Eur J Pediatr Surg (1996) 0.83
Second malignant neoplasms in patients treated on SIOP Wilms tumour studies and trials 1, 2, 5, and 6. Med Pediatr Oncol (1997) 0.82
Adult Wilms' tumour: review of 22 cases. Eur J Cancer (1994) 0.82
Paediatric surgical oncology. 5--Nephroblastoma. International Society of Paediatric Oncology (SIOP) Nephroblastoma Trial & Study Committee. Eur J Surg Oncol (1995) 0.82
High-performance liquid chromatographic determination of stabilized 4-hydroxyifosfamide in human plasma and erythrocytes. J Chromatogr B Biomed Sci Appl (1998) 0.82
Physical cell separation of neuroblastoma cells from bone marrow. Prog Clin Biol Res (1985) 0.82
[A French genetic and epidemiologic study on nephroblastoma: preliminary results]. Bull Cancer (1988) 0.82
Radiotherapy in the SIOP (International Society of Pediatric Oncology) nephroblastoma studies: a review. Med Pediatr Oncol (1994) 0.81
Urogenital rhabdomyosarcoma in children: is a conservative surgical approach justified? J Urol (1993) 0.80
The management of relapsed Wilms tumor. Hematol Oncol Clin North Am (1995) 0.80
Fetal rhabdomyomatous nephroblastoma: a tumour of good prognosis but resistant to chemotherapy. Eur J Cancer (1999) 0.80
[Treatment of childhood cancer in Africa. Action of the Franco-African childhood cancer group]. Med Trop (Mars) (2007) 0.80
Chromosome number 11 and Wilms' tumor. Cancer Genet Cytogenet (1982) 0.80
Preoperative chemotherapy in Wilms' tumour. Results of clinical trials and studies on nephroblastomas conducted by the International Society of Paediatric Oncology (SIOP). Prog Clin Biol Res (1982) 0.79
Fatal hepatic veno-occlusive disease with fibrinolysis as the cause of death during preoperative chemotherapy for nephroblastoma. Med Pediatr Oncol (1998) 0.79
Rhabdomyosarcomas: chemotherapy and limited supplementary treatment program to avoid mutilation. Natl Cancer Inst Monogr (1981) 0.79
Gas chromatographic determination of ifosfamide in microvolumes of urine and plasma. J Chromatogr (1991) 0.79
The advantages of preoperative therapy in Wilms' tumour. A summarised report on clinical trials conducted by the International Society of Paediatric Oncology (SIOP). Z Kinderchir (1985) 0.79
Radionuclide therapy of neural crest tumors. Med Pediatr Oncol (1987) 0.79
Stage and urinary catecholamine metabolite excretion in neuroblastoma. European Neuroblastoma Study Group. Lancet (1989) 0.79
Lack of protection of proximal tubular cells by amifostine (ethyol) in ifosfamide-containing regimens. Med Pediatr Oncol (2000) 0.78
Acute renal failure in high dose carboplatin chemotherapy. Med Pediatr Oncol (1995) 0.78
Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease. Cancer (1992) 0.78
Intracranial relapse in Wilms tumor patients. Pediatr Blood Cancer (2004) 0.78
Testing genomic imprinting in Wilm's tumor. Eur J Hum Genet (1993) 0.78
Determination of chloroacetaldehyde, a metabolite of oxazaphosphorine cytostatic drugs, in plasma. J Chromatogr (1993) 0.78
Acute lymphoblastic leukaemia after treatment of nephrotic syndrome with immunosuppressive drugs. Helv Paediatr Acta (1976) 0.77
Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo"). J Nucl Biol Med (1992) 0.77
The role of ifosfamide in paediatric soft tissue sarcomas. Cancer Chemother Pharmacol (1986) 0.77
131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma. Bull Cancer (1988) 0.77
Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer. Eur J Nucl Med (1994) 0.77
Ewing's sarcoma of the pelvis: changes over 25 years in treatment and results. Eur J Cancer (1997) 0.77